CrossrefInfokarte
Cell-free DNA fragmentomics and epigenomic profiling in hematologic malignancies: current evidence, translational limitations, and future directions
Translational Oncology · 2026-12 · 74 · 103080
DOI: 10.1016/j.tranon.2026.103080 ↗Abstract
Kein Abstract verfügbar.
EUVIMED